Patient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study

The well-established sequential use of topical calcipotriene and topical betamethasone dipropionate in combination has been shown to provide greater benefit than either monotherapy. A newer topical fixed combination formulation of calcipotriene 0.005% and betamethasone dipropionate 0.064% in a cream...

Full description

Saved in:
Bibliographic Details
Published inJournal of drugs in dermatology Vol. 22; no. 3; p. 271
Main Authors Kircik, Charles, Kircik, Leon
Format Journal Article
LanguageEnglish
Published United States 01.03.2023
Subjects
Online AccessGet more information

Cover

Loading…